Meta AnalysisID 1561

铋剂提高克拉霉素/甲硝唑/左氧氟沙星耐药幽门螺杆菌菌株根除率的疗效:系统评价与Meta分析

CRD42022313256

The aim is to investigate whether bismuth would improve the eradication rate of clarithromycin/metronidazole/levofloxacin-resistant H. pylori strains and how much more efficacy bismuth could achieve.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
1561
Evidence Id
10119
Core Evidence Id
10119
Source Meta Analysis Id
1515
Herb2 Meta Analysis Id
HBMA001515
Crd Id
CRD42022313256
Title
Efficacy of bismuth for improving the eradication rate of clarithromycin/metronidazole/levofloxacin-resistant Helicobacter pylori strains: a systemic review and meta‐analysis.
Review Question
The aim is to investigate whether bismuth would improve the eradication rate of clarithromycin/metronidazole/levofloxacin-resistant H. pylori strains and how much more efficacy bismuth could achieve.
Study Type Included
Randomized controlled trials (RCTs).
Condition Being Studied
Helicobacter pylori; eradiction rate of antibiotic-resistance strains; bismuth.
Participant
Inclusion: Adults with the infection of Helicobacter pylori. Exclusion: Adolescents (under 18 years of age).
Animal
Human Disease Modelled
Intervention
Bismuth containing therapy.
Comparator Control
Non-bismuth containing therapy.
Main Outcome
The pooled eradication rate for clarithromycin/metronidazole/levofloxacin-resistant Helicobacter pylori compared between bismuth containing therapy and non-bismuth containing therapy.
Outcome Measure
Additional Outcome
None.
Study Method
Intervention, Meta-analysis, Systematic review
Keyword
Bismuth; Clarithromycin; Helicobacter pylori; Humans; Levofloxacin; Metronidazole
Contact
Zhongxue Han [email protected]
Organisational Affiliation
Shandong University
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2022-02-25
Registration Date
2022-03-28
Anticipated Start Date
2022-02-01
Anticipated Completion Date
2022-03-26
Title Cn
铋剂提高克拉霉素/甲硝唑/左氧氟沙星耐药幽门螺杆菌菌株根除率的疗效:系统评价与Meta分析
Title En
Efficacy of bismuth for improving the eradication rate of clarithromycin/metronidazole/levofloxacin-resistant Helicobacter pylori strains: a systemic review and meta‐analysis.
Bilingual Status
complete